HP Inc. announced the appointment of David Meline to its Board of Directors.
Meline is the former Chief Financial Officer for Moderna Inc., a global biotechnology and pharmaceutical leader. His appointment is effective 1 November 2023.
“David has been instrumental in driving the growth and transformation of major global companies over the course of his four decades long career,” said Chip Bergh, Chair of HP’s Board of Directors. “His deep background and breadth of experience in finance, capital allocation, manufacturing, and technology makes him a terrific addition to the HP Board of Directors, as we deliver on our plans to drive long-term sustainable growth.”
Prior to Moderna, Meline served as the Chief Financial Officer for Amgen Inc. and 3M Company and spent more than 20 years at General Motors Company in various finance and management roles.
“We are delighted to welcome David to HP’s Board of Directors,” said HP Inc. President and CEO, Enrique Lores. “David’s track record of driving operational excellence, scaling growth businesses and delivering strong financial performance across industries will further strengthen our Board as we build a Future Ready HP.”
Meline currently serves on the Board of ABB Ltd., a publicly traded technology company specialising in electrification, motion and automation solutions, and the Los Angeles Philharmonic.
He holds a Bachelor’s degree in Mechanical Engineering from Iowa State University, a Master’s in Economics from the London School of Economics and Political Science, and a Master’s degree in Business Administration from The University of Chicago.
